Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS

Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMSDysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS, Published online: 24 April 2018; doi:10.1038/s41375-018-0140-yDysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS

Source: Leukemia - April 24, 2018 Category: Hematology Authors: Nasrin Rastgoo Maryam Pourabdollah Jahangir Abdi Donna Reece Hong Chang Source Type: research